Adaptation and Implementation of a Mobile Phone-Based Remote Symptom Monitoring System for People With Cancer in Europe.
cancer
methods
patient care
symptom management
telemedicine
Journal
JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844
Informations de publication
Date de publication:
14 Mar 2019
14 Mar 2019
Historique:
received:
18
04
2018
accepted:
12
12
2018
revised:
30
10
2018
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
15
3
2019
Statut:
epublish
Résumé
There has been an international shift in health care, which has seen an increasing focus and development of technological and personalized at-home interventions that aim to improve health outcomes and patient-clinician communication. However, there is a notable lack of empirical evidence describing the preparatory steps of adapting and implementing technology of this kind across multiple countries and clinical settings. This study aimed to describe the steps undertaken in the preparation of a multinational, multicenter randomized controlled trial (RCT) to test a mobile phone-based remote symptom monitoring system, that is, Advanced Symptom Management System (ASyMS), designed to enhance management of chemotherapy toxicities among people with cancer receiving adjuvant chemotherapy versus standard cancer center care. There were 13 cancer centers across 5 European countries (Austria, Greece, Ireland, Norway, and the United Kingdom). Multiple steps were undertaken, including a scoping review of empirical literature and clinical guidelines, translation and linguistic validation of study materials, development of standardized international care procedures, and the integration and evaluation of the technology within each cancer center. The ASyMS was successfully implemented and deployed in clinical practices across 5 European countries. The rigorous and simultaneous steps undertaken by the research team highlighted the strengths of the system in clinical practice, as well as the clinical and technical changes required to meet the diverse needs of its intended users within each country, before the commencement of the RCT. Adapting and implementing this multinational, multicenter system required close attention to diverse considerations and unique challenges primarily related to communication and clinical and technical issues. Success was dependent on collaborative and transparent communication among academics, the technology industry, translation partners, patients, and clinicians as well as a simultaneous and rigorous methodological approach within the 5 relevant countries.
Sections du résumé
BACKGROUND
BACKGROUND
There has been an international shift in health care, which has seen an increasing focus and development of technological and personalized at-home interventions that aim to improve health outcomes and patient-clinician communication. However, there is a notable lack of empirical evidence describing the preparatory steps of adapting and implementing technology of this kind across multiple countries and clinical settings.
OBJECTIVE
OBJECTIVE
This study aimed to describe the steps undertaken in the preparation of a multinational, multicenter randomized controlled trial (RCT) to test a mobile phone-based remote symptom monitoring system, that is, Advanced Symptom Management System (ASyMS), designed to enhance management of chemotherapy toxicities among people with cancer receiving adjuvant chemotherapy versus standard cancer center care.
METHODS
METHODS
There were 13 cancer centers across 5 European countries (Austria, Greece, Ireland, Norway, and the United Kingdom). Multiple steps were undertaken, including a scoping review of empirical literature and clinical guidelines, translation and linguistic validation of study materials, development of standardized international care procedures, and the integration and evaluation of the technology within each cancer center.
RESULTS
RESULTS
The ASyMS was successfully implemented and deployed in clinical practices across 5 European countries. The rigorous and simultaneous steps undertaken by the research team highlighted the strengths of the system in clinical practice, as well as the clinical and technical changes required to meet the diverse needs of its intended users within each country, before the commencement of the RCT.
CONCLUSIONS
CONCLUSIONS
Adapting and implementing this multinational, multicenter system required close attention to diverse considerations and unique challenges primarily related to communication and clinical and technical issues. Success was dependent on collaborative and transparent communication among academics, the technology industry, translation partners, patients, and clinicians as well as a simultaneous and rigorous methodological approach within the 5 relevant countries.
Identifiants
pubmed: 30869641
pii: v5i1e10813
doi: 10.2196/10813
pmc: PMC6437605
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10813Informations de copyright
©Eileen Furlong, Andrew Darley, Patricia Fox, Alison Buick, Grigorios Kotronoulas, Morven Miller, Adrian Flowerday, Christine Miaskowski, Elisabeth Patiraki, Stylianos Katsaragakis, Emma Ream, Jo Armes, Alexander Gaiger, Geir Berg, Paul McCrone, Peter Donnan, Lisa McCann, Roma Maguire. Originally published in JMIR Cancer (http://cancer.jmir.org), 14.03.2019.
Références
Cancer Nurs. 2002 Feb;25(1):1-7
pubmed: 11838715
Gastroenterology. 2004 Jan;126(1 Suppl 1):S124-8
pubmed: 14978648
Eur J Cancer Care (Engl). 2008 May;17(3):233-44
pubmed: 18419626
Eur J Oncol Nurs. 2008 Sep;12(4):380-6
pubmed: 18539527
Nurs Outlook. 2008 Sep-Oct;56(5):238-246.e2
pubmed: 18922277
Int J Nurs Stud. 2009 Apr;46(4):593-602
pubmed: 18947827
Support Care Cancer. 2009 Apr;17(4):437-44
pubmed: 18953579
Int J Palliat Nurs. 2008 Sep;14(9):426-31
pubmed: 19060793
Value Health. 2009 Jun;12(4):430-40
pubmed: 19138309
Eur J Cancer Care (Engl). 2009 Mar;18(2):156-64
pubmed: 19267731
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Int J Med Inform. 2009 Sep;78(9):588-604
pubmed: 19482542
Health Psychol. 2009 Jul;28(4):391-3
pubmed: 19594261
PLoS Med. 2009 Aug;6(8):e1000126
pubmed: 19688038
PLoS Med. 2009 Sep;6(9):e1000105
pubmed: 19753106
J Eval Clin Pract. 2011 Apr;17(2):268-74
pubmed: 20874835
Implement Sci. 2010 Oct 14;5:76
pubmed: 20946658
N Engl J Med. 2011 Mar 24;364(12):1090-1
pubmed: 21428764
Perspect Clin Res. 2010 Jul;1(3):106-9
pubmed: 21814631
J Med Internet Res. 2011 Dec 05;13(4):e111
pubmed: 22155738
Cancer Nurs. 2013 Jan-Feb;36(1):6-17
pubmed: 22495503
J Clin Oncol. 2013 Jul 10;31(20):2580-5
pubmed: 23733753
Nurs Outlook. 2014 Jan-Feb;62(1):59-63
pubmed: 24462021
Contemp Clin Trials. 2014 May;38(1):130-3
pubmed: 24735841
J Card Fail. 2014 Jul;20(7):513-21
pubmed: 24769270
Cancer Nurs. 2015 Mar-Apr;38(2):E37-47
pubmed: 24836956
Support Care Cancer. 2016 Apr;24(4):1897-906
pubmed: 26471280
Support Care Cancer. 2016 May;24(5):2163-2171
pubmed: 26563178
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Int Nurs Rev. 2017 Mar;64(1):33-41
pubmed: 26970420
JMIR Public Health Surveill. 2016 Jun 02;2(1):e28
pubmed: 27256208
J Med Internet Res. 2016 Aug 23;18(8):e229
pubmed: 27554525
BMC Health Serv Res. 2016 Oct 4;16(1):543
pubmed: 27716325
Eur J Oncol Nurs. 2017 Feb;26:63-82
pubmed: 28069154
Cancer Med. 2017 Mar;6(3):537-546
pubmed: 28135050
J Health Commun. 2017 Mar;22(3):274-284
pubmed: 28248626
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
BMC Cancer. 2017 May 8;17(1):318
pubmed: 28482877
BMJ Open. 2017 Jun 6;7(5):e015016
pubmed: 28592577
Adv Radiat Oncol. 2016 Feb 18;1(2):115-121
pubmed: 28740878
JMIR Cancer. 2017 Aug 08;3(2):e10
pubmed: 28790025
J Intensive Care Soc. 2016 Aug;17(3):234-237
pubmed: 28979496
Eur J Cancer Care (Engl). 2018 Nov;27(6):e12890
pubmed: 29993150